基本信息
views: 25
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Teplow is a leader in the areas of the structural biology of amyloid proteins and the biophysics of amyloid assembly. The Teplow laboratory seeks to understand and treat neurodegenerative disorders linked to pathologic protein folding. In AD, Abeta; self-associates to form a variety of oligomeric and polymeric structures with potent neurotoxic activities. Abeta; oligomers have been found in vivo in AD patients and may be the proximate neurotoxins in the disease. To understand how the nascent Abeta; monomer folds and assembles into neurotoxic forms, Dr. Teplow has employed an interdisciplinary strategy comprising in vivo, in vitro, in vacuo, and in silico approaches. The long-term goal is to discover the key factors controlling production of neurotoxic assemblies and then to target these factors in strategies for drug development.
Research Interests
Papers共 341 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Frontiers in physiology (2023): 1179315-1179315
NPJ Parkinson's diseaseno. 1 (2023): 139-10
NANO LETTERSno. 13 (2023): 6259-6268
Atsushi Michael Kimura,Mayumi Tsuji,Taro Yasumoto,Yukiko Mori,Tatsunori Oguchi, Yuya Tsuji,Masakazu Umino,Asami Umino,Toru Nishikawa,Shiro Nakamura,Tomio Inoue, Yuji Kiuchi,
FREE RADICAL BIOLOGY AND MEDICINE (2021): 232-244
Load More
Author Statistics
#Papers: 342
#Citation: 52141
H-Index: 110
G-Index: 228
Sociability: 7
Diversity: 3
Activity: 18
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn